The Zacks Chemicals Diversified industry is plagued by sluggish demand in certain markets, including consumer durables and building & construction, and some residual impacts of consumer inventory destocking. Lower consumer spending due to inflationary pressures in Europe and a slow recovery in China are impacting demand. Industry players like DuPont de Nemours, Inc. (DD) , FMC Corporation (FMC) and Cabot Corporation (CBT) are banking on strategic measures, including operating cost reductions and aggressive ...

Cabot Corporation's (CBT) shares have popped around 23% over the past three months. The rally has been fueled by CBT's strong earnings performance, upward revisions to earnings guidance and robust performance across its business segments. We are positive about the company's prospects and believe that the time is right for you to add the stock to your portfolio as it looks promising and is poised to carry the momentum ahead. Let's take a look into the factors that make CBT stock a compelling choice for inves ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. While many investors like to look for momen ...

Cabot Corporation's (CBT) shares have increased 16.1% in the past three months compared with the industry and the S&P 500's growth of 5% and 4.8%, respectively. Image Source: Zacks Investment Research Let's look at the factors driving the stock's price appreciation. What's Driving Cabot Stock? Cabot's Performance Chemicals division experienced strong growth in the fiscal third quarter, with sales rising 8.1% year over year to $332 million. The segment's EBIT saw an impressive 72% jump to $55 million, fueled ...

The Fed kicked off the new rate cycle era by initiating a 50 basis points cut in interest rates after holding it at a 23-year high for 14 consecutive months since July 2023. This marked the first rate cut since 2020 to address slowing economic growth. The shift in monetary policy, along with uncertainty surrounding the elections, has brought back the lure for dividend investing. While several dividend stocks could provide capital appreciation, zeroing in on stocks with a history of dividend growth leads to ...

Cabot Corporation's (CBT) shares reached a fresh 52-week high of $110.98 on Sept. 18 before closing at $107.85. CBT's stock has appreciated 55.8% in the past year against the industry's 4.3% fall. Image Source: Zacks Investment Research What's Driving Cabot? In the fiscal third quarter, Cabot's Performance Chemicals division posted robust growth, with sales climbing 8.1% year over year to $332 million. The segment's EBIT surged 72% to $55 million, driven by higher volumes and a favorable product mix, partic ...

Have you been paying attention to shares of Cabot (CBT) ? Shares have been on the move with the stock up 8.8% over the past month. The stock hit a new 52-week high of $108.39 in the previous session. Cabot has gained 28.7% since the start of the year compared to the -3.7% move for the Zacks Basic Materials sector and the -2.3% return for the Zacks Chemical - Diversified industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surprises, as it hasn't missed our ear ...

Cabot Corporation's (CBT) shares have increased 18% in the past six months compared with the industry's growth of 0.6% and the S&P 500's appreciation of 7.8% during the same period. Image Source: Zacks Investment Research Let's look at the factors driving the stock's price movement. What's Driving Cabot? In the fiscal third quarter, Cabot's Performance Chemicals division posted robust growth, with sales climbing 8.1% year over year to $332 million. The segment's EBIT surged 72% to $55 million, driven by hig ...

Wall Street is off to a poor start in September on renewed concerns about the health of the economy and the stock market's historical performance. Amid such a backdrop, investors are increasingly exploring strategies that will help them to protect their portfolios from downside risk. And nothing seems better than the strategy of dividend investing. Picking stocks with a history of dividend growth leads to a healthy portfolio with a greater scope of capital appreciation as opposed to simple dividend-paying s ...

Cabot Corporation (CBT) registered a 20.4% rise in its stock value in the past six months, fueled by strong earnings outperformance, upward revisions to earnings guidance and robust performance across its business segments. The stock offers an attractive investment opportunity with strong growth prospects, as reflected in its Zacks Rank #2 (Buy). Impressive Earnings Surprise History CBT has consistently outperformed the Zacks Consensus Estimate, delivering positive earnings surprises in each of the last fou ...